To survive inside the human bloodstream, the African trypanosome parasite covers itself with a protective layer made of proteins called variant surface glycoproteins (VSG). A study published in Nature Microbiology has now identified a key protein that allows the parasite to precisely control this protective “cloak.”
Researchers found that a newly identified protein, ESB2, plays a critical role in this process. It acts as a “molecular shredder,” enabling the parasite to stay hidden by cutting up selected parts of its genetic instructions as they are being produced.
Understanding this highly precise mechanism gives scientists new insight into weak points in the parasite’s life cycle. This could eventually lead to improved treatments for Sleeping Sickness, a disease that still has a major impact across sub-Saharan Africa.
Sleeping Sickness is spread by the bite of the tsetse fly. Without treatment, the parasite can enter the central nervous system, leading to serious symptoms such as disrupted sleep patterns, confusion, and coma.
“Molecular Shredder” Edits Genetic Instructions in Real Time
Dr. Joana Faria, senior author of the study and head of the research group at the University of York, explained: “We’ve discovered that the parasite’s secret to staying invisible isn’t just what it prints, but what it chooses to redact. By placing a ‘molecular shredder’ directly inside its ‘protein factory’, the parasite can edit its genetic manual in real-time.
“This suggests a fundamental shift in how we view infection: survival for many organisms may depend less on how they issue genetic instructions and more on how they destroy them at the source.”
Solving a 40-Year Mystery of Gene Expression
This discovery helps explain a long-standing mystery in the parasite’s biology that has puzzled scientists for decades. The genetic instructions that produce the parasite’s protective “cloak” also include several “helper genes” that support survival and immune evasion. Based on this setup, scientists expected the parasite to produce similar amounts of each protein.
Instead, the parasite produces large quantities of cloak proteins while generating only small amounts of helper proteins. The new findings reveal that this imbalance is not accidental.
By identifying ESB2, the research team showed that the parasite regulates its genetic output by destroying certain instructions rather than simply controlling how much is produced.
Precision Control Inside the Expression Site Body
ESB2 is located within the parasite’s protein production center, known as the Expression Site Body. As genetic instructions are being processed, ESB2 acts like a “molecular blade,” immediately cutting apart the helper gene sections while leaving the cloak-related instructions untouched.
This real-time editing ensures the parasite produces exactly what it needs to remain undetected by the host’s immune system.
Breakthrough From University of York Research Team
The discovery represents the first major achievement from Dr. Faria’s new laboratory at the University of York and contributes to the city’s growing reputation as a center for life sciences research.
The project was funded by a Sir Henry Dale Fellowship — a partnership between the Wellcome Trust and the Royal Society — and brought together researchers from the United Kingdom, Portugal, the Netherlands, Germany, Singapore and Brazil.
Lianne Lansink, first author of the study, said: “When we first saw the molecular shredder localised in the microscope, we knew we had found something special.”
Dr. Faria added: “This discovery is a real full-circle moment for me. The mystery of how this parasite manages the asymmetric expression of its genetic manual has been a cold case in the back of my mind since my days as a postdoc. To finally solve it now, as the first major output of my own lab here at York, is incredibly rewarding. It’s a testament to what a fresh lab and a diverse group of scientists can achieve when they look at an old problem from a completely new angle.”








